Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Diabetes

Date Submitted: Oct 1, 2020
Date Accepted: May 5, 2021

The final, peer-reviewed published version of this preprint can be found here:

Improving Management of Type 2 Diabetes Using Home-Based Telemonitoring: Cohort Study

Milani R

Improving Management of Type 2 Diabetes Using Home-Based Telemonitoring: Cohort Study

JMIR Diabetes 2021;6(2):e24687

DOI: 10.2196/24687

PMID: 34110298

PMCID: 8231880

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Improving Management of People with Type 2 Diabetes Using Digital Tools

  • Richard Milani

ABSTRACT

Background:

Diabetes is present in 10.5% of the U.S. population and accounts for 14.3% of all office-based physician visits made by adults. Despite this established office-based approach, the disease and its adverse outcomes, including glycemic control and clinical events, tend to worsen over time. Available home technology now provides accurate, reliable data that can be transmitted directly to the electronic medical record.

Objective:

To evaluate the impact of a virtual, home-based diabetes management program on clinical measures of diabetes control compared to usual care.

Methods:

We evaluated glycemic control and other diabetes-related measures after one year in 763 patients with type 2 diabetes enrolled into a home-based digital medicine diabetes program and compared them to 794 patients matched for age, sex, race, BMI, A1C, creatinine, eGFR, and insulin use in a usual care group after one year. Digital medicine patients completed questionnaires on-line, received medication management and lifestyle recommendations from a clinical pharmacist or APP and a health coach, and were asked to submit blood glucose readings using a commercially available Bluetooth enabled glucose meter that transmitted data directly to the electronic medical record.

Results:

After one-year, usual care patients demonstrated no significant changes in A1C (7.3±1.7 to 7.3±1.6; P =.41), or in the proportion of patients with A1C ≥ 9.0 (15% to 14%; P = .51). Digital medicine patients demonstrated improvements in A1C (7.3±1.5 to 6.9±1.2; P <.001), the proportion of patients with A1C ≥ 9.0 (14% to 6%; P <.001), diabetes distress (26% to 16%; P <.001), and in hypoglycemic episodes (41.1% to 11.9%; P <.001).

Conclusions:

A digital diabetes program is associated with significant improvement in glycemic control and other diabetes measures. Utilization of a virtual health intervention using connected devices was widely accepted across a broad range of ethnic diversity, ages, and levels of health literacy.


 Citation

Please cite as:

Milani R

Improving Management of Type 2 Diabetes Using Home-Based Telemonitoring: Cohort Study

JMIR Diabetes 2021;6(2):e24687

DOI: 10.2196/24687

PMID: 34110298

PMCID: 8231880

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.